Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway
Xiaozhong Liao(Sun Yat-sen University), Lingling Sun(Second Affiliated Hospital of Zhejiang University), Zhe‐Sheng Chen(St. John's University), Haiyan Du(Guangzhou University of Chinese Medicine), Hanrui Chen(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Zhuo‐Xun Wu(St. John's University), Jing Wang(Lishui Central Hospital), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Wei Guo(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Jue Zhang(Chengdu University), Lan-Ting Tao(First Affiliated Hospital of Guangzhou University of Chinese Medicine)
Cited by 19
Related Papers
Microbiota in health and diseases
|Signal Transduction and Targeted Therapy|2022|2.9k
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Assessment of the Physicochemical Properties and Biological Effects of Water Activated by Non‐thermal Plasma Above and Beneath the Water Surface
|Plasma Processes and Polymers|2014|261
Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects
|Journal of Ginseng Research|2021|127
Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex
|Journal of Advanced Research|2023|103